Andrew James Regan's most recent trade in Conduit Pharmaceuticals Inc was a trade of 154,799 Common Stock done at an average price of $3.2 . Disclosure was reported to the exchange on June 3, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Conduit Pharmaceuticals Inc | Andrew James Regan | Director, Chief Executive Officer, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 3.23 per share. | 03 Jun 2025 | 154,799 | 154,799 | - | 3.2 | 500,001 | Common Stock |
| Conduit Pharmaceuticals Inc | Andrew James Regan | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 0.32 per share. | 14 Jun 2024 | 10,244,392 | 1,691,727 | - | 0.3 | 3,246,448 | Common Stock |
| Conduit Pharmaceuticals Inc | Andrew James Regan | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 0.26 per share. | 14 Jun 2024 | 1,514,100 | 177,627 | - | 0.3 | 391,092 | Common Stock |
| Conduit Pharmaceuticals Inc | Andrew James Regan | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 0.25 per share. | 14 Jun 2024 | 1,389,820 | 12,941,319 | - | 0.2 | 343,425 | Common Stock |
| Conduit Pharmaceuticals Inc | Andrew James Regan | Director, Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 14 Jun 2024 | 1,100,000 | 30,048,454 | - | - | Common Stock | |
| Conduit Pharmaceuticals Inc | Andrew James Regan | Director, Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 14 Jun 2024 | 1,100,000 | 15,478,695 | - | - | Common Stock | |
| Conduit Pharmaceuticals Inc | Andrew James Regan | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 0.25 per share. | 14 Jun 2024 | 1,005,200 | 11,936,119 | - | 0.2 | 248,385 | Common Stock |
| Conduit Pharmaceuticals Inc | Andrew James Regan | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 0.30 per share. | 14 Jun 2024 | 582,952 | 14,631,139 | - | 0.3 | 173,253 | Common Stock |
| Conduit Pharmaceuticals Inc | Andrew James Regan | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 0.29 per share. | 14 Jun 2024 | 300,000 | 14,331,139 | - | 0.3 | 87,000 | Common Stock |
| Conduit Pharmaceuticals Inc | Andrew James Regan | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 0.33 per share. | 14 Jun 2024 | 150,000 | 15,214,091 | - | 0.3 | 50,070 | Common Stock |
| Conduit Pharmaceuticals Inc | Andrew James Regan | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 0.44 per share. | 14 Jun 2024 | 77,681 | 15,364,091 | - | 0.4 | 33,853 | Common Stock |
| Conduit Pharmaceuticals Inc | Andrew James Regan | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 0.51 per share. | 14 Jun 2024 | 35,923 | 15,441,772 | - | 0.5 | 18,321 | Common Stock |
| Conduit Pharmaceuticals Inc | Andrew James Regan | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 0.64 per share. | 14 Jun 2024 | 1,000 | 15,477,695 | - | 0.6 | 640 | Common Stock |